-
MSD's $20 billion "sweep" has reached another climax: whose feast is the "raging" ADC?
With the rise of the ADC drug race track, major pharmaceutical companies are competing for potential blockbuster drugs from ADC, causing global ADC drug cooperation transactions to rise all the way. ...